Urinary TIMP-2 × IGFBP7 and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients

Although combining the results of TIMP-2 × IGFBP7 and PCT may be a useful tool to identify and stratify ICU patients at high risk for septic AKI and short-term adverse outcomes, data should be confirmed in a large prospective study.